VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA
Description
About VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA
The Varicella-zoster virus (VZV) (strain Dumas) Major viral transcription factor Peptide (IEDB: 108277) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Major viral transcription factor Peptide, H-ALWALPHAA-OH (Uniprot: P09310 aa: 544-551) from JPT is produced under strict quality control and quality management.
VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA - Specifications
- Peptide sequence: H-ALWALPHAA-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Herpes zoster
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA
References:
Read References with JPT’s Antigen Peptides
VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA has been described in:
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation., J Virol, 2009 (PMID: 19386715)
Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing., PLoS One, 2015 (PMID: 26509579)
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen., Blood, 2012 (PMID: 22529286)
Documentation
Documentation for VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA
Properties
Properties of VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Herpes zoster |
Layout: | Freeze-dried in glass vial |
Organism: | Varicella-zoster virus (VZV) |
Protein Name: | Major viral transcription factor |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to VZV (strain Dumas) Major viral transcription factor 544-551, ALWALPHAA
Information | Values |
---|---|
Sequence: | H-ALWALPHAA-OH |
Specifications: | 9mer peptide as TFA salt |